Managing diabetes can be challenging, but technology has made it significantly easier for many people. One such technological advancement is the insulin pump, a device that delivers insulin ...

Pelayo was introduced to inhaled insulin by her endocrinologist, Dr. Nora Barsony. “It's a little tiny powder that goes right ...

In 1993, the Diabetes Control and Complications Trial (DCCT) definitively showed that achieving and maintaining glucose values as close to normal as possible in people with type 1 diabetes will ...

ORLANDO -- For type 1 diabetes patients, switching from an insulin pump or multiple daily injections to inhaled insulin (Afrezza) maintained glycemic control -- for those who used it as intended, the ...

ORLANDO, Fla. — The inhaled insulin Afrezza combined with a long-acting basal analog offers a non-inferior insulin treatment option for people with type 1 diabetes, new phase 4 data suggest. Afrezza ...

Medically reviewed by Mary Choy, PharmD Key Takeaways Insulin is needed to manage your blood sugar levels if you have type 1 ...

Abbott’s latest innovation, the FreeStyle Libre® 2 Plus sensor, is available for the first time for t:slim X2™ insulin pump users in the U.S. Tandem’s Control-IQ™ hybrid closed-loop technology now ...

Tandem Diabetes Care (TNDM) begins global commercial rollout of t:slim X2 pump integration with the FreeStyle Libre 3 Plus CGM sensor, expanding choice and personalization for people living with ...

ORLANDO -- Putting type 2 diabetes patients on an automated insulin delivery (AID) pump improved glycemic control, the SECURE-T2D pivotal trial showed. Type 2 diabetes patients started on the Omnipod ...

“The commercial availability of this new offering is a testament to our decade-long partnership with Dexcom and shared commitment to continued leadership in advancing AID systems,” said Mark Novara, ...